arrow
L

Lawson Eng

University Health Network
H指数:26
被引数:2,077

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prioritizing implementation strategies to enhance smoking cessation delivery in cancer care in Ontario, Canada: a modified Delphi study

在加拿大安大略省癌症护理中优先实施策略以增强戒烟服务递送:一项改良德尔菲研究

2026-10-290
OAAI
Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) — a systematic review and network meta-analysis

奥氮平(10 mg vs 5 mg vs 2.5 mg)预防化疗诱导的恶心和呕吐(CINV)——一项系统评价和网络Meta分析

2026-07-160
OAAI
The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM Classification

国际肺癌研究协会分期项目:吸烟状况对第九版TNM分类中肺癌分期的影晌

2025-09-080
PRE
The prognostic and predictive value of pre-treatment hematologic markers for oropharyngeal carcinoma stratified by HPV status and treated with definitive (chemo) radiation

根据HPV状态分层且接受根治性(化疗)放疗的口咽癌患者,其治疗前血液学标志物的预后和预测价值。

2025-06-010
OAAI
Outcomes following IMRT alone in head and neck squamous cell carcinoma ordinarily managed with concurrent chemo-radiotherapy

头颈部鳞状细胞癌中,仅采用IMRT(调强放射治疗)的预后结果,通常与采用同期放化疗的管理方式进行比较。

2025-06-010
PRE
Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations

TP53共突变在具有罕见可治疗驱动基因突变非小细胞肺癌患者中的预后和预测效果

2025-02-010
PRE
Health Utility and Symptom Scores in Patients With Advanced Malignant Pleural Mesothelioma Treated in a Real-World Setting

晚期恶性胸膜间皮瘤患者在真实世界治疗中的健康效用和症状评分

2025-02-010
OAAI
Development of a prediction model for tube feeding dependence in HPV-associated oropharyngeal cancer patients undergoing chemoradiotherapy

HPV相关口咽癌放化疗患者管饲依赖预测模型的建立

2025-02-011
OAAI
Assessing the feasibility and external validity of natural language processing-extracted data for advanced lung cancer patients

评估自然语言处理提取数据在晚期肺癌患者中的可行性与外部有效性

2025-01-010
OAAI
Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations
2024-12-230
OAAI
The impact of body mass index (BMI) on immune-related adverse events (irAEs) and acute care use among patients receiving immune checkpoint inhibitors (ICIs): A population-based study

身体质量指数(BMI)对接受免疫检查点抑制剂(ICIs)治疗患者免疫相关不良事件(irAEs)及急性医疗资源使用的影响:一项基于人群的研究

2024-09-010
PRE